Dr. George Whitesides is a Co-Founder and serves as Board Member & Chairman of Scientific Advisory Board at Nano Terra. Dr. George serves as Chairman and Director at Diagnostics For All. Whitesides serves as Chief Scientific Advisor at Material Impact Fund. He serves as Executive at Breakthrough Energy Ventures. He is a Co-Founder & Board Member at Soft Robotics. He was the Co-Founder at Surface Logix. He joined Harvard's Department of Chemistry in 1982 and served as department chairman from 1986 to 1989. From 1963 to 1982, he was a faculty member at Massachusetts Institute of Technology. Dr. Whitesides held advisory positions on the National Research Council, National Science Foundation and the Department of Defense's Defense Advanced Research Projects Agency (DARPA), and he is a member of the American Academy of Arts and Sciences, National Academy of Sciences, National Academy of Engineering and the American Philosophical Society, among other organizations. He has received dozens of honors, including the American Chemical Society (ACS) Award in Pure Chemistry (1975), the Arthur C. Cope Award (1995), the DARPA Award for Significant Technical Achievement (1996), the National Medal of Science (1998), the Von Hippel Award (2000), the Kyoto Prize (2003), the Dan David Award (2005), the Welch Award (2005), the Priestley Award (2007), the American Institute of Chemists Gold Medal (2007), the Prince of Asturias Foundation Award (2008), the Nanoscience Prize (2008), the Wheland Medal (2008) and the Benjamin Franklin Medal in Chemistry (2009). In addition to Aresenal Medical, George is a co-founder of a number of companies including Genzyme, GelTex, Theravance and 480 Biomedical. He received a Bachelor of Arts from Harvard University in 1960 and a doctorate from the California Institute of Technology in 1964. He also serves as Advisor at NGP Energy Technology Partners.